134 related articles for article (PubMed ID: 3860186)
1. Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis.
Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1985 May; 27(5):708-11. PubMed ID: 3860186
[TBL] [Abstract][Full Text] [Related]
2. Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1987 Mar; 31(3):458-60. PubMed ID: 3472489
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits.
Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1983 Sep; 24(3):321-4. PubMed ID: 6685454
[TBL] [Abstract][Full Text] [Related]
4. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Gilbert M; Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1986 Mar; 29(3):461-3. PubMed ID: 3459391
[TBL] [Abstract][Full Text] [Related]
5. Cefoperazone treatment of experimental endocarditis.
Snepar RA; Carrizosa J; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1981 May; 19(5):773-6. PubMed ID: 6457556
[TBL] [Abstract][Full Text] [Related]
6. Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.
Levison ME; Kobasa WD
Antimicrob Agents Chemother; 1984 Jun; 25(6):683-6. PubMed ID: 6742813
[TBL] [Abstract][Full Text] [Related]
7. Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1988 Feb; 32(2):262-4. PubMed ID: 3163241
[TBL] [Abstract][Full Text] [Related]
8. Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates.
Heifetz CL; Bien PA; Cohen MA; Dombrowski ME; Griffin TJ; Malta TE; Sesnie JC; Shapiro MA; Wold SA
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():29-42. PubMed ID: 3129392
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
Papadakis JA; Samonis G; Maraki S; Boutsikakis J; Petrocheilou V; Saroglou G
Chemotherapy; 2000; 46(2):116-21. PubMed ID: 10671762
[TBL] [Abstract][Full Text] [Related]
10. [Experimental Enterobacter cloacae endocarditis treated with gentamicin. Predictive value of the in vitro bactericidal rate].
Potel G; Caillon J; Bugnon D; Lecomte P; Drugeon HB; Baron D
Pathol Biol (Paris); 1988 May; 36(5):536-9. PubMed ID: 3043353
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.
Rudrik JT; Cavalieri SJ; Britt EM
Antimicrob Agents Chemother; 1984 Jul; 26(1):97-100. PubMed ID: 6591853
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strains.
Bassey CM; Baltch AL; Smith RP; Conley PE
Antimicrob Agents Chemother; 1984 Sep; 26(3):417-8. PubMed ID: 6439116
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.
Fuchs PC; Barry AL; Jones RN; Thornsberry C
Diagn Microbiol Infect Dis; 1985 May; 3(3):213-21. PubMed ID: 3858044
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1983 Nov; 24(5):754-63. PubMed ID: 6229216
[TBL] [Abstract][Full Text] [Related]
15. An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
Foot M; Williams G; Want S; Roe M; Quaghebeur G; Bates S
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():97-103. PubMed ID: 3129393
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of enoxacin compared with norfloxacin and amikacin.
van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental endocarditis due to penicillin-resistant Streptococcus pneumoniae.
Fernández Guerrero ML; Arbol F; Verdejo C; Fernández Roblas R; Soriano F
Antimicrob Agents Chemother; 1994 May; 38(5):1103-6. PubMed ID: 8067745
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin (LY146032) treatment of experimental enterococcal endocarditis.
Bush LM; Boscia JA; Kaye D
Antimicrob Agents Chemother; 1988 Jun; 32(6):877-81. PubMed ID: 2843085
[TBL] [Abstract][Full Text] [Related]
20. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
Fantin B; Leclercq R; Arthur M; Duval J; Carbon C
Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
